Nachu, M., Stevenson, P., Quach, K., Martino, C., Percival, M., Halpern, A., Becker, P., Oehler, V., Cooper, J. P., Orozco, J., Hendrie, P., Walter, R., Ghiuzeli, C. M., Mawad, R., Cassaday, R. (2025). Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) yields durable remissions and survival in adults with newly diagnosed acute lymphoblastic leukemia/lymphoma (ALL): Long-term follow-up of a prospective trial. Blood. https://doi.org/10.1182/blood-2025-5128